Study Evaluating the Efficacy and Safety of PRT-2761 for the Treatment of Acute and Chronic Allergic Conjunctivitis
| Status: | Completed |
|---|---|
| Conditions: | Allergy, Ocular |
| Therapuetic Areas: | Ophthalmology, Otolaryngology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/17/2018 |
| Start Date: | October 13, 2017 |
| End Date: | February 18, 2018 |
A Single-Center, Randomized, Double-Masked, Vehicle and Active-Controlled, Dose-Ranging Phase 2 Study Evaluating the Efficacy and Safety of PRT-2761 for the Treatment of Acute and Chronic Allergic Conjunctivitis Using the Conjunctival Allergen Challenge Model (Ora-CAC®)
To evaluate the efficacy and safety of two concentrations of PRT-2761 as a topical ophthalmic
solution for the treatment of the signs and symptoms of acute and chronic allergic
conjunctivitis.
solution for the treatment of the signs and symptoms of acute and chronic allergic
conjunctivitis.
Inclusion Criteria:
- be at least 18 years old
- be willing and able to avoid all disallowed medications and contact lenses
- must have a pregnancy test if of childbearing potential
- must be able to read an eye chart from 10 feet away
Exclusion Criteria:
- must not have any allergies to the study medications
- must not have any ocular or non ocular condition that investigator feels will
interfere with study parameters
- must not have used an investigational drug or device in the past 30 days or
concurrently enrolled in another investigational trial
We found this trial at
1
site
Click here to add this to my saved trials
